Reference:
Chetty, S. (2021). Dr Chetty’s 8th day therapy for COVID-19. Covexit. Retrieved from [URL]
Summary:
Dr Shankara Chetty’s 8th Day Therapy for COVID-19 addresses the inflammatory phase occurring after Day 8 of infection, aiming to prevent severe disease progression. The document outlines four key interventions starting at this critical juncture. First, corticosteroids like Prednisone are administered to halt hypersensitivity reactions and mitigate potential cytokine storms. Second, antihistamines, such as Promethazine and Cimetidine, are used to eliminate released histamines. Third, anti-leukotrienes like Montelukast assist in clearing leukotrienes from the body. Finally, blood thinners, including Aspirin, help manage platelet activation factors. Optional interventions may include antibiotics for bacterial co-infections and other supportive medications based on individual patient needs. This therapy is intended solely for informational purposes and should not replace professional medical advice. It is crucial for individuals to seek immediate medical assistance upon experiencing COVID-19 symptoms, particularly on Day 8, when severe complications are most likely to arise. Accurate tracking of symptom onset is essential for timely intervention and management.